Zobrazeno 1 - 10
of 363
pro vyhledávání: '"Glise, H."'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Psychology, Health & Medicine. Nov98, Vol. 3 Issue 4, p417. 11p. 3 Graphs.
Publikováno v:
European Journal of Surgery. Dec98 Supplement 582, p128-131. 4p.
Publikováno v:
Gut. 53:22ii-25
Neural information from the viscera to the central nervous system (CNS) plays a very important role in health and disease. Afferent neural activity from the gastrointestinal tract signals the CNS but the nature of the stimuli required to activate the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b367eda9b7fe3151189f9ab2654b5522
https://doi.org/10.1136/gut.2003.033472
https://doi.org/10.1136/gut.2003.033472
Autor:
Junghard O, O Anker-Hansen, A Stubberöd, Glise H, Troels Havelund, H. Hernqvist, Tore Lind, Carlsson R, Svend Arne Pedersen, Karsten Lauritsen, Lundell L
Publikováno v:
Scandinavian Journal of Gastroenterology. 32:974-979
Background: Data are limited on the value of effective antisecretory therapy in the relief of heartburn in patients without oesophagitis. Methods: Patients with heartburn, without endoscopic signs of oesophagitis, were randomized to double-blind trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::772c939453a28eb9f2c69693de0ec58e
https://doi.org/10.3109/00365529709011212
https://doi.org/10.3109/00365529709011212
Autor:
Glise H
Publikováno v:
Scandinavian Journal of Gastroenterology. 30:38-42
BACKGROUND AND RESULTS IN THE LITERATURE: Reflux symptoms are common, with an incidence of up to 40% monthly and 7% daily in the general adult population. The duration of symptoms in patients seeking help for reflux is often in excess of 5 years in a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b8583d53ca846601a2eb8373831ed15
https://doi.org/10.3109/00365529509090268
https://doi.org/10.3109/00365529509090268
Publikováno v:
Bollling-Sternevald, E, Lauritsen, K, Talley, N J, Junghard, O & Glise, H 2003, ' Is it possible to predict treatment response to a proton pump inhibitor in functional dyspepsia? ', Alimentary Pharmacology and Therapeutics, vol. 18, pp. 117-24 .
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3062::cc2e2cdee574a48fc09a96f17ee001a3
https://portal.findresearcher.sdu.dk/da/publications/e17344b0-ba9a-11dc-9626-000ea68e967b
https://portal.findresearcher.sdu.dk/da/publications/e17344b0-ba9a-11dc-9626-000ea68e967b
Autor:
Bolling-Sternevald, E., Carlsson, R., Aalykke, C., Wilson, B.V.L., Junghard, O., Glise, H., Lauritsen, K.
Publikováno v:
Bolling-Sternevald, E, Carlsson, R, Aalykke, C, Wilson, B V L, Junghard, O & Glise, H L K 2002, ' Self-administered symptom questionnaires in patients with dyspepsia and their yield in discriminating between endoscopic diagnoses ', Digestive Diseases, vol. 20, pp. 191-8 .
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3062::58677b1e260a4110181b75b72f374f55
https://portal.findresearcher.sdu.dk/da/publications/8b8898a0-6fcf-11db-81a9-000ea68e967b
https://portal.findresearcher.sdu.dk/da/publications/8b8898a0-6fcf-11db-81a9-000ea68e967b
Publikováno v:
Lind, T, Havelund, T, Lundell, L, Glise, H, Lauritsen, K & Pedersen, S A M F 1999, ' On demand therapy with omeprazole for the long-term management of patients with heartburn without oesophagitis-a placebo-controlled randomized trial ', Alimentary Pharmacology and Therapeutics, vol. 13, pp. 907-914 .
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3062::e42aa8418c743c2cdec0ba0a1de576b4
https://portal.findresearcher.sdu.dk/da/publications/f3ee48e0-ba97-11dc-9626-000ea68e967b
https://portal.findresearcher.sdu.dk/da/publications/f3ee48e0-ba97-11dc-9626-000ea68e967b
Autor:
Hallerbäck B, Glise H
Publikováno v:
Scandinavian journal of gastroenterology. Supplement. 199
In this workshop Quality of Life (QOL) was discussed in relation to other measures such as treatment efficacy and cost-benefit in evaluation of clinical treatments. Demands from regulatory authorities, patients as well as nurses and doctors were beli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27c473f67eba67e908b74df4ccb944dd
https://pubmed.ncbi.nlm.nih.gov/8171301
https://pubmed.ncbi.nlm.nih.gov/8171301